20 June 2013
Keywords: actelion, drops, emea, indication, extension, zavesca, european
Article | 03 March 2008
The European Medicines Agency (EMEA) says it has been formally notified
by Swiss drug firm Actelion of its decision to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 March 2008
19 June 2013
© 2013 thepharmaletter.com